Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
NPJ Breast Cancer
|
December 3, 2025
CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen
Nealia C House, Maxine M Chen, Sima Khazaei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 19, 2020
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
Carminia M Della Corte, Triparna Sen, Carl M Gay, et al.
Cancer Cell
|
December 15, 2023
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Yunfan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Research
|
September 18, 2025
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer
Yongkun Wei, Minghui Liu, Er-Yen Yen, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancer
Jiehui Deng, David H Peng, David Fenyo, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS <sup>G12D</sup> inhibition in pancreatic ductal adenocarcinoma
Kathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Nature Communications
|
July 3, 2021
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma
Yun-Fan Sun, Liang Wu, Shi-Ping Liu, et al.
Nature Cancer
|
June 18, 2021
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer
Jiehui Deng, Aatish Thennavan, Igor Dolgalev, et al.
Nature Cancer
|
August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Science Translational Medicine
|
January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma
Xiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
NPJ Breast Cancer
|
December 3, 2025
CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen
Nealia C House, Maxine M Chen, Sima Khazaei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 19, 2020
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype
Carminia M Della Corte, Triparna Sen, Carl M Gay, et al.
Cancer Cell
|
December 15, 2023
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
Yunfan Sun, Pin Wu, Zefan Zhang, et al.
Cancer Research
|
September 18, 2025
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer
Yongkun Wei, Minghui Liu, Er-Yen Yen, et al.
Biorxiv : the Preprint Server for Biology
|
May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancer
Jiehui Deng, David H Peng, David Fenyo, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS <sup>G12D</sup> inhibition in pancreatic ductal adenocarcinoma
Kathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Nature Communications
|
July 3, 2021
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma
Yun-Fan Sun, Liang Wu, Shi-Ping Liu, et al.
Nature Cancer
|
June 18, 2021
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer
Jiehui Deng, Aatish Thennavan, Igor Dolgalev, et al.
Nature Cancer
|
August 5, 2024
Co-targeting SOS1 enhances the antitumor effects of KRAS<sup>G12C</sup> inhibitors by addressing intrinsic and acquired resistance
Venu Thatikonda, Hengyu Lyu, Sabine Jurado, et al.
Science Translational Medicine
|
January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma
Xiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Page
of 6